Dow Up0.08% Nasdaq Down0.30%

Enzo Biochem Inc. (ENZ)

-NYQ
5.32 Down 0.32(5.67%) 4:04PM EDT
ProfileGet Profile for:
Enzo Biochem Inc.
527 Madison Avenue
New York, NY 10022
United States - Map
Phone: 212-583-0100
Website: http://www.enzo.com

Details 
Index Membership:N/A
Sector:Healthcare
Industry:Medical Laboratories & Research
Full Time Employees:423

Business Summary 

Enzo Biochem, Inc., an integrated life sciences and biotechnology company, is engaged in the research, development, manufacture, and marketing of diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. The company operates in three segments: Clinical Labs, Life Sciences, and Therapeutics. The Clinical Labs segment provides routine and esoteric clinical laboratory tests or procedures used in general patient care by physicians to establish or support a diagnosis, monitor treatment or medication, and search for an otherwise undiagnosed condition. This segment operates a full-service clinical laboratory in Farmingdale, New York; a network of approximately 35 patient service centers in New York and New Jersey; and a standalone laboratory in the New York, as well as a full-service phlebotomy, in-house logistics department, and information technology department. The Life Sciences segment manufactures, develops, and markets products and tools to life sciences, drug development, and clinical research customers. It offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide tools for target identification/validation, high content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis to life science researchers. This segment offers its products to scientific experts primarily in the fields of cancer, cardiovascular disease, neurological disorders, diabetes and obesity, endocrine disorders, infectious and autoimmune disease, hepatotoxicity, and renal injury. The Therapeutics segment is involved in research and development of therapeutic drug candidates in the areas of gastrointestinal, infectious, ophthalmic, and metabolic diseases. The company markets its products and services through its direct sales force. Enzo Biochem, Inc. was founded in 1976 and is headquartered in New York, New York.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on Enzo Biochem Inc.

Corporate Governance 
Enzo Biochem Inc.’s ISS Governance QuickScore as of Sep 1, 2014 is 10. The pillar scores are Audit: 1; Board: 8; Shareholder Rights: 9; Compensation: 10.
Brought to you by Institutional Shareholder Services (ISS)

Key Executives 
 PayExercised
Dr. Elazar Rabbani Ph.D., 71
Co-Founder, Chairman, Chief Exec. Officer and Sec.
963.00K0.00
Mr. Barry W. Weiner , 64
Co Founder, Pres, Chief Financial Officer, Principal Accounting Officer, Treasurer and Director
820.00K0.00
Mr. David C. Goldberg , 57
VP of Corp. Devel. and Interim Gen. Mang. of Enzo Clinical Labs
309.00K0.00
Mr. Andrew P. Whiteley , 56
VP of Bus. Devel. and Chief Operating Officer of Enzo Life Sciences Inc
283.00K0.00
Dr. Bernard L. Kasten Jr., Ph.D., M.D., 68
Lead Independent Director, Chairman of Compensation Committee, Member of Audit Committee and Member of Nominating/Governance Committee
87.00KN/A
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders